Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathrin Brisken

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Reproductive Toxicology (Elmsford, N.Y.)|June 9, 2026
A mouse intraductal model (MIND) for investigating responses to endocrine exposures in the normal human breast epithelium in vivoHazel Quinn, Laura Battista, Cathrin Brisken
Endocrine-Related Cancer|March 23, 2018
The challenges of modeling hormone receptor-positive breast cancer in miceBerna C Özdemir, George Sflomos, Cathrin Brisken
Endocrinology|March 29, 2024
Is There a Special Role for Ovarian Hormones in the Pathogenesis of Lobular Carcinoma?Renée L Flaherty, George Sflomos, Cathrin Brisken
Journal of Mammary Gland Biology and Neoplasia|February 20, 2004
Using gene expression arrays to elucidate transcriptional profiles underlying prolactin functionSandra Gass, Jessica Harris, Chris Ormandy, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2006
Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary glandSonia Mallepell, Andrée Krust, Pierre Chambon, et al.
Breast Cancer Research : BCR|July 20, 2012
ER and PR signaling nodes during mammary gland developmentTamara Tanos, Lucia Rojo, Pablo Echeverria, et al.
Journal of Mammary Gland Biology and Neoplasia|May 25, 2013
Does cancer start in the womb? altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptorsAna M Soto, Cathrin Brisken, Cheryl Schaeberle, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 22, 2024
Preclinical Mouse Intraductal Model (MIND) to Study Metastatic Dormancy in Estrogen Receptor-Positive Breast CancerHazel M Quinn, Laura Battista, Valentina Scabia, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2002
The signaling domain of the erythropoietin receptor rescues prolactin receptor-mutant mammary epitheliumCathrin Brisken, Merav Socolovsky, Harvey F Lodish, et al.
Genesis (New York, N.Y. : 2000)|September 30, 2023
Tumor dormancy: EMT beyond invasion and metastasisPatrick Aouad, Hazel M Quinn, Adeline Berger, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Reproductive Toxicology (Elmsford, N.Y.)|June 9, 2026
A mouse intraductal model (MIND) for investigating responses to endocrine exposures in the normal human breast epithelium in vivoHazel Quinn, Laura Battista, Cathrin Brisken
Endocrine-Related Cancer|March 23, 2018
The challenges of modeling hormone receptor-positive breast cancer in miceBerna C Özdemir, George Sflomos, Cathrin Brisken
Endocrinology|March 29, 2024
Is There a Special Role for Ovarian Hormones in the Pathogenesis of Lobular Carcinoma?Renée L Flaherty, George Sflomos, Cathrin Brisken
Journal of Mammary Gland Biology and Neoplasia|February 20, 2004
Using gene expression arrays to elucidate transcriptional profiles underlying prolactin functionSandra Gass, Jessica Harris, Chris Ormandy, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2006
Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary glandSonia Mallepell, Andrée Krust, Pierre Chambon, et al.
Breast Cancer Research : BCR|July 20, 2012
ER and PR signaling nodes during mammary gland developmentTamara Tanos, Lucia Rojo, Pablo Echeverria, et al.
Journal of Mammary Gland Biology and Neoplasia|May 25, 2013
Does cancer start in the womb? altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptorsAna M Soto, Cathrin Brisken, Cheryl Schaeberle, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 22, 2024
Preclinical Mouse Intraductal Model (MIND) to Study Metastatic Dormancy in Estrogen Receptor-Positive Breast CancerHazel M Quinn, Laura Battista, Valentina Scabia, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2002
The signaling domain of the erythropoietin receptor rescues prolactin receptor-mutant mammary epitheliumCathrin Brisken, Merav Socolovsky, Harvey F Lodish, et al.
Genesis (New York, N.Y. : 2000)|September 30, 2023
Tumor dormancy: EMT beyond invasion and metastasisPatrick Aouad, Hazel M Quinn, Adeline Berger, et al.
Pageof 9